THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea
· Delayed Price · Currency is KRW 5,530.00
-90.00 (-1.60%)
At close: Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Biochemical Diagnostics | 2.92B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnostics Growth | -9.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics | 1.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics Growth | -40.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostics | 462.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostics Growth | 11.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 255.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 597.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 255.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 597.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Other | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America | 4.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | 3986.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 2.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -8.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 939.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 21.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|